137 related articles for article (PubMed ID: 32586182)
1. Eyelid basal cell carcinoma with neuroendocrine differentiation: a case report and literature review.
Chung IY; McKelvie P; Chen Y
Orbit; 2021 Aug; 40(4):316-319. PubMed ID: 32586182
[TBL] [Abstract][Full Text] [Related]
2. Staged excision of primary periocular basal cell carcinoma: absence of residual tumour in re-excised specimens: a 10-year series.
McGrath LA; Meeney A; Currie ZI; Mudhar HS; Tan JH
Br J Ophthalmol; 2019 Jul; 103(7):976-979. PubMed ID: 30181140
[TBL] [Abstract][Full Text] [Related]
3. Management of periocular basal cell carcinoma with modified en face frozen section controlled excision.
Wong VA; Marshall JA; Whitehead KJ; Williamson RM; Sullivan TJ
Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):430-5. PubMed ID: 12439056
[TBL] [Abstract][Full Text] [Related]
4. A multicentre review of the histology of 1012 periocular basal cell carcinomas.
Lin Z; Qidwai U; Igali L; Hemmant B
Eur J Ophthalmol; 2021 Sep; 31(5):2699-2704. PubMed ID: 32907383
[TBL] [Abstract][Full Text] [Related]
5. [Recurrence risk of periocular basal cell carcinoma after histologically controlled excision].
Dethmers A; Löw U; Langenbucher A; Flockerzi F; Bohle RM; Seitz B
Ophthalmologie; 2023 Mar; 120(3):285-293. PubMed ID: 36112203
[TBL] [Abstract][Full Text] [Related]
6. CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?
Yirmibeş S; Adım ŞB; Saraydaroğlu Ö
J Cutan Pathol; 2023 Jan; 50(1):56-61. PubMed ID: 36054407
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients.
Fatigato G; Capitani S; Milani D; Grassilli S; Alameen AA; Candiani M; Riberti C; Galasso M; Previati M
Eur J Dermatol; 2017 Aug; 27(4):363-368. PubMed ID: 28524055
[TBL] [Abstract][Full Text] [Related]
8. Primary Cribriform Carcinoma of the Eyelid With Neuroendocrine Features: A Case Report.
Fox JD; Dubovy SR; Wester ST; Nouri K
J Drugs Dermatol; 2017 Feb; 16(2):173-174. PubMed ID: 28300861
[TBL] [Abstract][Full Text] [Related]
9. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
[TBL] [Abstract][Full Text] [Related]
10. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
Hamada S; Kersey T; Thaller VT
Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
[TBL] [Abstract][Full Text] [Related]
11. Small margin (up to 2 mm) excision of periocular basal cell carcinomas in the setting of a one-stop clinic - long-term outcomes at a minimum of 11 years' follow-up.
Peden R; Radwan M; Wright M
Eye (Lond); 2020 Nov; 34(11):2036-2040. PubMed ID: 31965082
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
13. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
[TBL] [Abstract][Full Text] [Related]
14. Reproducible Histopathologic Features in Cases of Basal Cell Carcinoma With Neuroendocrine Expression: A Clinicopathologic Study of 24 Cases With a Potential Diagnostic Pitfall.
Plaza JA; Pootrakul L; Raghavan SS; Sangueza M; Gru AA
Am J Dermatopathol; 2021 Dec; 43(12):903-907. PubMed ID: 34783706
[TBL] [Abstract][Full Text] [Related]
15. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Factors Related to Eyelid Basal Cell Carcinoma in Saudi Arabia.
Al Wohaib M; Al Ahmadi R; Al Essa D; Maktabbi A; Khandekar R; Al Sharif E; Al Katan H; Schellini SA; Al Shaikh O
Middle East Afr J Ophthalmol; 2018; 25(2):96-102. PubMed ID: 30122855
[TBL] [Abstract][Full Text] [Related]
17. Mucin-producing sweat gland carcinoma of the eyelid: diagnostic and prognostic considerations.
Hoguet A; Warrow D; Milite J; McCormick SA; Maher E; Della Rocca R; Della Rocca D; Goldbaum A; Milman T
Am J Ophthalmol; 2013 Mar; 155(3):585-592.e2. PubMed ID: 23218693
[TBL] [Abstract][Full Text] [Related]
18. Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period.
Tuppurainen K
Graefes Arch Clin Exp Ophthalmol; 1995 Apr; 233(4):205-8. PubMed ID: 7797084
[TBL] [Abstract][Full Text] [Related]
19. 'Fast-tracking' cancer referrals: application for periocular basal cell carcinoma.
Bhatnagar A; Mohamad S; Sandramouli S
Eye (Lond); 2006 Apr; 20(4):428-30. PubMed ID: 15877094
[TBL] [Abstract][Full Text] [Related]
20. [Periocular basal cell carcinoma].
González F; García A
Arch Soc Esp Oftalmol; 2005 May; 80(5):275-82. PubMed ID: 15918094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
